<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-2Q2QKVJO</identifier><date>2023</date><creator>Reberšek, Martina</creator><relation>documents/doc/2/URN_NBN_SI_doc-2Q2QKVJO_001.pdf</relation><relation>documents/doc/2/URN_NBN_SI_doc-2Q2QKVJO_001.txt</relation><format format_type="type">article</format><format format_type="extent">Str. 35-37</format><identifier identifier_type="COBISSID_HOST">141491203</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-2Q2QKVJO</identifier><language>slv</language><publisher publisher_location="Ljubljana">Katedra za onkologijo</publisher><publisher publisher_location="Ljubljana">Onkološki inštitut</publisher><publisher publisher_location="Ljubljana">Sekcija za internistično onkologijo</publisher><source>Novosti v imunoterapiji 2022</source><rights>InC</rights><subject language_type_id="slv">imunoterapija</subject><subject language_type_id="slv">onkologija</subject><subject language_type_id="slv">onkološko zdravljenje</subject><title>Microbiome and immunotherapy</title><title>Mikrobiom in imunoterapija</title></Record>